Blogs

Improvement Advisor for UCLPartners, Alexandra Hellyer reflects on how a Quality Improvement (QI) approach could have helped her to deal with the uncertainty of suffering from Long COVID.

Matt Kearney on supporting primary care to do things differently and at scale as we emerge from the pandemic. Discussing the expansion of NHS Proactive Care @home, and how the UCLPartners Proactive Care Frameworks assist to deliver optimised care for long term conditions.

Dr Swapna Mandal and Alexandra Hellyer from our patient safety team share how learning from respiratory teams at acute hospitals during the COVID-19 pandemic can be harnessed to improve practice in the future.

Helen Craig discusses how patient and public involvement and engagement sat at the heart of a new programme to support people with long COVID, ensuring that the work focused on the symptoms that matter to patients – and that the digital solution was useable for all.

As a GP working over the course of the pandemic across multiple GP sites, but predominantly in Enfield, I have been quite overwhelmed by the rise in the incidence of patients presenting with worsening of chronic conditions such as diabetes, hypertension and asthma and COPD.

Network Development Lead Sophie Bulmer shares some of the key insights discussed in a recent webinar about the vaccination programme in London.

There is a need to change how rapid service evaluation is funded, co-ordinated and delivered, not just during but beyond the pandemic to enable more effective scale-up of health and care innovations, writes Prof Mike Roberts.

UCLPartners Health Technology Advisor Gareth Cairns discusses how point of care and at home testing has come to the fore in the pandemic and looks at some examples that are proving valuable in this space.

A major concern for general practice is how to continue with the essential covid response while providing proactive care to patients who are at highest risk of deterioration.

Health and care services have innovated quickly in response to the pandemic. But how do we evaluate rapid implementations made at scale?